- Home
- LHX vs EW Comparison
LHX vs EW Comparison
Compare LHX & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LHX | EW |
|---|---|---|
| Founded | 1895 | 1958 |
| Country | United States | United States |
| Employees | 45000 | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.3B | 49.9B |
| IPO Year | 2001 | 1999 |
Fundamental Metrics
Financial Performance| Metric | LHX | EW |
|---|---|---|
| Price | $293.11 | $87.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 21 |
| Target Price | ★ $353.80 | $96.37 |
| AVG Volume (30 Days) | 978.0K | ★ 4.8M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.56% | N/A |
| EPS Growth | ★ 8.39 | N/A |
| EPS | ★ 2.72 | 0.66 |
| Revenue | ★ $6,182,000,000.00 | $6,067,600,000.00 |
| Revenue This Year | $8.25 | $13.39 |
| Revenue Next Year | $7.58 | $9.81 |
| P/E Ratio | ★ $108.34 | $132.50 |
| Revenue Growth | 4.78 | ★ 11.55 |
| 52 Week Low | $247.00 | $72.30 |
| 52 Week High | $379.23 | $89.60 |
Technical Indicators
Market Signals| Indicator | LHX | EW |
|---|---|---|
| Relative Strength Index (RSI) | 39.25 | 56.20 |
| Support Level | $285.22 | $81.73 |
| Resistance Level | $305.52 | $89.48 |
| Average True Range (ATR) | 8.51 | 2.34 |
| MACD | 0.27 | -0.07 |
| Stochastic Oscillator | 11.76 | 65.16 |
Price Performance
Historical ComparisonAbout LHX L3Harris Technologies Inc.
In addition to its legacy software-defined radio franchise, L3Harris Technologies has through a series of acquisitions established franchises producing uncrewed aerial vehicles, sensors, avionics, space-based systems, missiles, and solid rocket motors. It is also adept at refitting civilian aircraft for military use, provides military and commercial training services, and maintains the US Federal Aviation Administration's communications infrastructure.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.